1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Overdose Awareness/Recovery Month Events, 2026 - RFA #112: DBH-FY26 Treatment Services is sponsored by Ohio Department of Behavioral Health. This Request for Applications (RFA) is administered by the Ohio Department of Behavioral Health to community providers, nonprofits, local Alcohol, Drug Addiction, and Mental Health (ADAMH) Boards and similar eligible community organizations who promote and provide treatment, pre…
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Community providers, nonprofits, local Alcohol, Drug Addiction, and Mental Health (ADAMH) Boards and similar eligible community organizations in Ohio who promote and provide treatment, prevention, and recovery services. Confirm the full requirements in the official notice before applying.
Overdose Awareness/Recovery Month Events, 2026 - RFA #112: DBH-FY26 Treatment Services is funded by Ohio Department of Behavioral Health. Verify program details on the funder's official page before applying.
This opportunity targets applicants in Ohio. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
BJA opened five FY2026 competitions covering reentry, family-based substance use treatment, opioid response and crisis stabilization, with award ceilings from $1 million to $3 million. Grants.gov closes September 24 and 25; JustGrants closes October 1 and 2. The seven-day gap between them is the single most common reason a finished DOJ application never gets reviewed.
Read articleARPA-H selected 13 research teams for EVIDENT, a $139.4M initiative to develop objective clinical endpoints for rapid-acting behavioral health therapies including psilocybin. At least $50M will match state psychedelic research investments under a Trump executive order.
Read articleARPA-H's $139.4M EVIDENT initiative selects 13 research teams to build objective biomarkers for psilocybin, neuromodulation, and rapid-acting mental health therapies.
Read article